Tapewire

Nasdaq · USD

OBX

Obsidian Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4898
SEC CIK
0002130606
Parsed reports
14

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2026 Filed Aug 5, 2026 20:08 UTC GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335083 · ownership.xml · derivative · entry 1

Norkunas Matthew · CIK 0001816836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:07 UTC GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335078 · ownership.xml · derivative · entry 1

Barrett Peter · CIK 0001291895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:05 UTC
Fardis MariaDirector
GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335045 · ownership.xml · derivative · entry 1

Fardis Maria · CIK 0001559231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:06 UTC
Hagen HeidiDirector
GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335055 · ownership.xml · derivative · entry 1

Hagen Heidi · CIK 0001585084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:10 UTC GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335113 · ownership.xml · derivative · entry 1

ROSS ROBERT W. · CIK 0001733077 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Jagasia MadanDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 37,653 $0.00 Strike: $12.00 $0.00
Disclosure

SEC source: 0001193125-26-335082 · ownership.xml · derivative · entry 1

Jagasia Madan · CIK 0002144943 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,653

Underlying: Common Stock · 37,653 shares

Expires 2036-08-02

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.